Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Stomach Neoplasms 34 Ovarian Neoplasms 31 Peritoneal Neoplasms 28 Fallopian Tube Neoplasms 14 Colorectal Neoplasms 14 Carcinoma, Ovarian Epithelial 13 Appendiceal Neoplasms 7 Neoplasm Metastasis 5 Pancreatic Neoplasms 4 Uterine Neoplasms 3 Recurrence 3 Pseudomyxoma Peritonei 3 Neoplasms 3 Carcinoma 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Peritoneal Diseases 2 Mesothelioma, Malignant 2 Mesothelioma 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gastrointestinal Neoplasms 2 Gastric Adenocarcinoma 2 Desmoplastic Small Round Cell Tumor 2 Colonic Neoplasms 2 Wilms Tumor 1 Stomach Diseases 1 Stage Ⅲ Gastric Cancer 1 Stage IV Gastric Cancer With Metastasis 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1

Interventions

Oxaliplatin 2 Paclitaxel 1 Hyperthermic Intraperitoneal Chemotherapy 1 Cytoreduction Surgical Procedures 1 Bupivacaine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Cancer × Hyperthermic Intraperitoneal Chemotherapy × Clear all

NCT04122885 2019-10-10

IMMUNOPAC

University Hospital Tuebingen

Peritoneal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡